Lantheus Holdings, Inc. (NASDAQ:LNTH) Accelerates Toward Near-Term Takeover After Strong Cash Position

Momentum centers on a corporate-control event and a robust liquidity profile that together set a defined near-term boundary for market action. Technical indicators signal a low-strength, mixed-momentum environment while fundamentals show solid margins alongside elevated valuation multiples.

Recent News

On August 3, 2026 the company announced a definitive agreement to merge with Curium US Holdings LLC; the transaction sets a fixed-cash offer and contingent value rights tied to future commercial milestones. On August 6, 2026 Lantheus released its second-quarter 2026 financial results and noted the pending merger in its business update, including references to product and regulatory progress announced earlier in 2026.

Technical Analysis

ADX at 10.75 indicates no trend; directional indicators show weakening upside and growing downside pressure as DI+ declines to 18.49 while DI- has experienced a dip-and-reversal into 22.90, a configuration aligned with bearish directional pressure despite low trend strength.

MACD sits at -0.39 with the MACD trend labeled peak & reversal, which denotes bearish momentum; however the MACD currently trades marginally above its signal line (-0.44), creating a short-lived bullish crossover against the background of declining momentum.

MRO reads 15.69 and is increasing, indicating price currently sits above the model target and carries moderate potential for downward reversion; that suggests the market has priced a premium relative to the calculated target and pressure toward the target exists.

RSI at 47.55 with a decreasing trend reflects neutral-to-weakening momentum and supports a range-bound to slightly bearish near-term bias rather than strong directional conviction.

Price sits near the short-term envelope: close $100.32 versus the 20-day average $100.69 and 50-day average $102.17, with the 12-day EMA showing a peak & reversal pattern; the 200-day average ($85.36) remains well below the current price, preserving the longer-term uptrend context while short-term averages suggest mild distribution.

Bollinger bands compress tightly (20-day st. dev. $0.29), and Ichimoku components place the price marginally below the Kijun (101.01) and Tenkan (100.80), indicating limited upside momentum until the price clears near-term cloud levels and the super trend upper at $102.31 offers a clear short-term resistance boundary.

 


Fundamental Analysis

Revenue for the period totaled $388,180,000 with year-over-year revenue growth roughly +2.9% (revenue growth factor 1.02893). Operating metrics show gross margin of 62.31% and an operating margin of 25.82%, producing an EBIT of $98,740,000 and EBITDA of $121,322,000. EBIT margin measures 25.44%, above the industry peer mean of 10.70% and above the peer median of 19.38%, indicating stronger operating profitability versus the provided peer central tendency.

EPS came in at $1.55 versus an estimate of $1.30, producing an EPS surprise of +19.23% (EPS difference $0.25). Forward EPS sits at $1.594 and forward P/E 59.70; trailing P/E registers 64.35 and the PEG ratio reads 10.44, signaling elevated valuation multiples relative to near-term earnings growth expectations.

Liquidity and balance-sheet metrics display strength: cash and short-term investments total $593,298,000, current ratio 305.97%, quick ratio 288.82%, and cash ratio 176.75%, collectively providing ample near-term funding flexibility. Total debt stands at $624,958,000 with debt-to-assets 25.88% and debt-to-EBITDA ~5.15x, indicating leverage that remains serviceable given an interest coverage ratio near 20.09.

Free cash flow totaled $89,868,000 with a free cash flow yield of 1.38% and free cash to net income about 119.78%, reflecting conversion of earnings into cash but producing a modest yield relative to the enterprise value. Asset turnover remains low at 0.163, and return on equity measures 5.72% with return on invested capital near 4.19%, demonstrating modest capital efficiency despite healthy margins.

Valuation context: enterprise value approximates $6.54 billion with an enterprise multiple of 53.92 and price-to-sales around 16.77. The P/B ratio registers 4.96, roughly in line with the industry peer mean of 4.89. The current valuation as determined by WMDST: over-valued.

MOST-RECENT QUARTERLY REPORT
REPORT PERIOD ENDING: 2026-06-30
REPORT DATE: 2026-08-06
NEXT REPORT DATE: 2026-11-05
CASH FLOW  Begin Period Cash Flow 500.3 M
 Operating Cash Flow 92.2 M
 Capital Expenditures -2.33 M
 Change In Working Capital 11.1 M
 Dividends Paid
 Cash Flow Delta 94.7 M
 End Period Cash Flow 595.0 M
 
INCOME STATEMENT REVENUE
 Total Revenue 388.2 M
 Forward Revenue 134.6 M
COSTS
 Cost Of Revenue 146.3 M
 Depreciation 22.6 M
 Depreciation and Amortization 22.6 M
 Research and Development 38.2 M
 Total Operating Expenses 288.0 M
PROFITABILITY
 Gross Profit 241.9 M
 EBITDA 121.3 M
 EBIT 98.7 M
 Operating Income 100.2 M
 Interest Income 6.3 M
 Interest Expense 4.9 M
 Net Interest Income 1.3 M
 Income Before Tax 93.8 M
 Tax Provision 18.8 M
 Tax Rate 20.0 %
 Net Income 75.0 M
 Net Income From Continuing Operations 75.0 M
EARNINGS
 EPS Estimate 1.30
 EPS Actual 1.55
 EPS Difference 0.25
 EPS Surprise 19.231 %
 Forward EPS 1.59
 
BALANCE SHEET ASSETS
 Total Assets 2.4 B
 Intangible Assets 928.4 M
 Net Tangible Assets 383.4 M
 Total Current Assets 1.0 B
 Cash and Short-Term Investments 593.3 M
 Cash 593.3 M
 Net Receivables 352.9 M
 Inventory 57.6 M
 Long-Term Investments 59.7 M
LIABILITIES
 Accounts Payable 48.1 M
 Short-Term Debt 697.0 K
 Total Current Liabilities 335.7 M
 Net Debt
 Total Debt 625.0 M
 Total Liabilities 1.1 B
EQUITY
 Total Equity 1.3 B
 Retained Earnings 873.0 M
VALUATION & PER-SHARE METRICS EQUITY & PER-SHARE METRICS
 Book Value Per-Share 20.10
 Shares Outstanding 65.265 M
 Revenue Per-Share 5.95
VALUATION
 Market Capitalization 6.5 B
 Enterprise Value 6.5 B
 Enterprise Multiple 53.921
Enterprise Multiple QoQ 90.575 %
Enterprise Multiple YoY 43.947 %
Enterprise Multiple IPRWA high: 296.418
mean: 62.146
median: 55.135
LNTH: 53.921
low: -183.285
 EV/R 16.852
CAPITAL STRUCTURE
 Asset To Equity 1.841
 Asset To Liability 2.189
 Debt To Capital 0.323
 Debt To Assets 0.259
Debt To Assets QoQ -2.94 %
Debt To Assets YoY -11.019 %
Debt To Assets IPRWA high: 1.375
median: 0.28
mean: 0.27
LNTH: 0.259
low: 0.003
 Debt To Equity 0.476
Debt To Equity QoQ -7.701 %
Debt To Equity YoY -9.685 %
Debt To Equity IPRWA high: 2.28
LNTH: 0.476
mean: 0.433
median: 0.379
low: -1.742
PRICE-BASED VALUATION
 Price To Book (P/B) 4.963
Price To Book QoQ 18.49 %
Price To Book YoY 23.863 %
Price To Book IPRWA high: 19.444
LNTH: 4.963
mean: 4.892
median: 2.286
low: -4.924
 Price To Earnings (P/E) 64.354
Price To Earnings QoQ 48.458 %
Price To Earnings YoY -9.458 %
Price To Earnings IPRWA high: 344.308
mean: 85.948
median: 69.659
LNTH: 64.354
low: -262.561
 PE/G Ratio 10.44
 Price To Sales (P/S) 16.771
Price To Sales QoQ 24.632 %
Price To Sales YoY 35.62 %
Price To Sales IPRWA high: 102.682
mean: 21.351
LNTH: 16.771
median: 14.212
low: 0.201
FORWARD MULTIPLES
Forward P/E 59.703
Forward PE/G 9.686
Forward P/S 48.892
EFFICIENCY OPERATIONAL
 Operating Leverage -13.488
ASSET & SALES
 Asset Turnover Ratio 0.163
Asset Turnover Ratio QoQ -1.17 %
Asset Turnover Ratio YoY -10.041 %
Asset Turnover Ratio IPRWA high: 0.581
mean: 0.183
LNTH: 0.163
median: 0.162
low: 0.0
 Receivables Turnover 1.096
Receivables Turnover Ratio QoQ 3.71 %
Receivables Turnover Ratio YoY -0.684 %
Receivables Turnover Ratio IPRWA high: 4.716
mean: 1.586
median: 1.509
LNTH: 1.096
low: 0.254
 Inventory Turnover 2.462
Inventory Turnover Ratio QoQ 5.929 %
Inventory Turnover Ratio YoY 17.911 %
Inventory Turnover Ratio IPRWA high: 3.276
LNTH: 2.462
mean: 0.785
median: 0.649
low: 0.016
 Days Sales Outstanding (DSO) 83.28
CASH CYCLE
 Cash Conversion Cycle Days (CCC) 91.042
Cash Conversion Cycle Days QoQ -5.762 %
Cash Conversion Cycle Days YoY -7.182 %
Cash Conversion Cycle Days IPRWA high: 495.615
mean: 138.227
median: 132.02
LNTH: 91.042
low: -294.725
CAPITAL DEPLOYMENT
 Cash Conversion Ratio 0.561
 CapEx To Revenue -0.006
 CapEx To Depreciation -0.103
 
CAPITAL, LIQUIDITY & COVERAGE CAPITAL STRUCTURE
 Total Capital 1.9 B
 Net Invested Capital 1.9 B
 Invested Capital 1.9 B
 Net Tangible Assets 383.4 M
 Net Working Capital 691.4 M
LIQUIDITY
 Cash Ratio 1.767
 Current Ratio 3.06
Current Ratio QoQ 8.181 %
Current Ratio YoY -28.682 %
Current Ratio IPRWA high: 12.91
LNTH: 3.06
mean: 2.513
median: 2.126
low: 0.303
 Quick Ratio 2.888
Quick Ratio QoQ 9.23 %
Quick Ratio YoY -29.007 %
Quick Ratio IPRWA high: 8.948
LNTH: 2.888
mean: 1.898
median: 1.616
low: 0.336
COVERAGE & LEVERAGE
 Debt To EBITDA 5.151
 Cost Of Debt 0.629 %
 Interest Coverage Ratio 20.09
Interest Coverage Ratio QoQ -39.408 %
Interest Coverage Ratio YoY -9.735 %
Interest Coverage Ratio IPRWA high: 388.789
mean: 23.71
LNTH: 20.09
median: 11.42
low: -653.8
 Operating Cash Flow Ratio 0.317
TIMING / LIQUIDITY
 Days Payables Outstanding (DPO) 29.288
DIVIDENDS
 Dividend Coverage Ratio
 Dividend Payout Ratio
 Dividend Rate
 Dividend Yield
PERFORMANCE GROWTH
 Asset Growth Rate 2.901 %
 Revenue Growth 2.875 %
Revenue Growth QoQ -139.71 %
Revenue Growth YoY 102.893 %
Revenue Growth IPRWA high: 50.0 %
median: 8.466 %
mean: 7.982 %
LNTH: 2.875 %
low: -21.903 %
 Earnings Growth 6.164 %
Earnings Growth QoQ -20.812 %
Earnings Growth YoY -37.128 %
Earnings Growth IPRWA high: 134.286 %
mean: 18.6 %
median: 13.971 %
LNTH: 6.164 %
low: -150.0 %
MARGINS
 Gross Margin 62.305 %
Gross Margin QoQ 1.809 %
Gross Margin YoY -2.27 %
Gross Margin IPRWA high: 92.958 %
median: 64.039 %
LNTH: 62.305 %
mean: 59.436 %
low: -8.114 %
 EBIT Margin 25.437 %
EBIT Margin QoQ -40.483 %
EBIT Margin YoY -12.126 %
EBIT Margin IPRWA high: 63.968 %
LNTH: 25.437 %
median: 19.381 %
mean: 10.695 %
low: -792.605 %
 Return On Sales (ROS) 25.817 %
Return On Sales QoQ 19.784 %
Return On Sales YoY 10.95 %
Return On Sales IPRWA high: 43.228 %
LNTH: 25.817 %
median: 19.153 %
mean: 10.25 %
low: -1054.013 %
CASH FLOW
 Free Cash Flow (FCF) 89.9 M
 Free Cash Flow Yield 1.38 %
Free Cash Flow Yield QoQ -42.524 %
Free Cash Flow Yield YoY -12.492 %
Free Cash Flow Yield IPRWA high: 17.278 %
LNTH: 1.38 %
median: 1.113 %
mean: 1.042 %
low: -56.428 %
 Free Cash Growth -26.278 %
Free Cash Growth QoQ -152.795 %
Free Cash Growth YoY 3.432 %
Free Cash Growth IPRWA high: 447.609 %
mean: -6.444 %
median: -9.348 %
LNTH: -26.278 %
low: -491.065 %
 Free Cash To Net Income 1.198
 Cash Flow Margin 27.413 %
 Cash Flow To Earnings 1.418
VALUE & RETURNS
 Economic Value Added 0.04
 Return On Assets (ROA) 3.152 %
Return On Assets QoQ -39.127 %
Return On Assets YoY -16.525 %
Return On Assets IPRWA high: 23.439 %
LNTH: 3.152 %
mean: 1.739 %
median: 1.348 %
low: -69.189 %
 Return On Capital Employed (ROCE) 4.749 %
 Return On Equity (ROE) 0.057
Return On Equity QoQ -41.441 %
Return On Equity YoY -15.259 %
Return On Equity IPRWA high: 1.096
LNTH: 0.057
mean: 0.049
median: 0.025
low: -1.474
 DuPont ROE 5.945 %
 Return On Invested Capital (ROIC) 4.194 %
Return On Invested Capital QoQ -38.765 %
Return On Invested Capital YoY -11.78 %
Return On Invested Capital IPRWA high: 13.429 %
LNTH: 4.194 %
mean: 2.826 %
median: 1.784 %
low: -19.66 %

Six-Week Outlook

Near-term movement should respect two dominant forces: corporate-event certainty from the announced merger and technical ambiguity driven by low ADX and conflicting momentum signals. The announced transaction establishes a near-term valuation floor anchored by the offer terms and contingent milestones; technically, expect range-bound activity between the immediate support near recent close ($100.32) and resistance at the super trend upper ($102.31) while volatility remains compressed.

Momentum indicators favor guarded caution: MACD’s peak & reversal and a declining RSI argue for limited upside follow-through unless momentum re-accelerates, while the positive but rising MRO warns of a reversion toward model targets. For swing timeframes, monitor volume spikes for breakout conviction and any regulatory or deal-timing disclosures that could abruptly shift the range-bound pattern.

About Lantheus Holdings, Inc.

Lantheus Holdings, Inc. (NASDAQ:LNTH) develops, manufactures, and commercializes diagnostic and therapeutic products to aid clinicians in diagnosing and treating cardiovascular, oncological, and other diseases globally. The company provides DEFINITY, an injectable ultrasound enhancing agent for echocardiography exams, and TechneLite, a technetium generator for nuclear medicine procedures. It also offers Xenon-133, a radiopharmaceutical gas for pulmonary function assessment, and Neurolite, an imaging agent for identifying brain blood flow disruptions due to stroke. Lantheus Holdings offers Cardiolite, an imaging agent for assessing cardiac blood flow, and PYLARIFY, a PET imaging agent targeting PSMA-positive lesions in prostate cancer patients. Their portfolio includes the Automated Bone Scan Index for prostate cancer burden calculation and RELISTOR for opioid-induced constipation. Additionally, the company provides aPROMISE and PYLARIFY AI, AI-based medical device software for prostate cancer imaging assessment. The company develops products like 1095, a PSMA-targeted therapy, PNT2002 for mCRPC, and MK-6240, a PET imaging agent targeting Tau tangles in Alzheimer’s disease. Lantheus collaborates with GE Healthcare, NanoMab Technology, and others. Founded in 1956, the company is headquartered in Bedford, Massachusetts.



© 2026 WMDST — The World’s Most Dangerous Swing Trader. All rights reserved.